Scientists discovered a hidden CB₁ receptor pocket and engineered a drug to exploit it, offering promise of safer, more ...

A newly published study has found that an oral cannabinoid formulation was more effective than the prescription drug ...

Mira Pharmaceuticals to acquire SKNY in a stock-based deal valuing both firms near $30 million each, backed by third-party pipeline valuation reports.

The world of hemp-derived cannabinoids is evolving fast, with new compounds emerging regularly. Two of the latest to generate ...

Combining the cannabinoid cannabinol (CBN) with the breast cancer drug exemestane may significantly improve treatment ...

A new study published in eGastroenterology explores the role of gut cannabinoid receptor 1 (CB1R) in alcohol binge-induced ...